Dyne Therapeutics, Inc.
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
DYN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1560 TRAPELO ROAD, 2451 WALTHAM
- Website:
- https://dyne-tx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies for people with genetically driven neuromuscular diseases. The company utilizes its proprietary FORCE™ platform to create targeted therapeutics that address the root cause of these disorders, with the goal of delivering significant functional improvement. Dyne is advancing a broad pipeline of treatments, including candidates for conditions such as Duchenne muscular dystrophy. Its pioneering approach focuses on enhancing the delivery of therapeutic molecules directly to muscle tissue to combat serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Dyne Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dyne Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dyne Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
